Fresenius Kabi is a global healthcare company that develops and supplies essential medical products and services. Its operations span over 100 countries, with its therapies reaching almost 450 million patients annually. The company employs more than 43,000 people worldwide.
The company's work is organized across four business segments. Its Pharma division produces injectable drugs and IV therapy solutions. The Biopharma unit focuses on developing biosimilars for therapeutic areas including autoimmune diseases and oncology. In Nutrition, Fresenius Kabi manufactures parenteral and enteral nutrition products. Its MedTech segment builds infusion systems, blood collection devices, and technologies for cell and gene therapy.
Technology underpins the development, manufacturing, and delivery of these products at a global scale. The company's portfolio requires sustained engineering and digital capabilities, from the hardware and software embedded in its infusion and blood collection systems to the complex biopharmaceutical and cell therapy manufacturing processes.
